Perspective Therapeutics (CATX) Share-based Compensation (2010 - 2026)
Perspective Therapeutics recorded quarterly Share-based Compensation of $2.6 million in Q1 2026, up 10.57% quarter-over-quarter from $2.3 million in Q4 2025, and up 21.69% year-over-year from $2.1 million in Q1 2025.
Perspective Therapeutics' Share-based Compensation history runs 17 years deep, the most recent figure standing at $2.6 million for Q1 2026.
- In Q1 2026, Share-based Compensation rose 21.69% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $9.4 million (up 40.67% YoY), while the FY2025 annual figure was $9.0 million, up 71.73% from the prior year.
- Share-based Compensation came in at $2.6 million for Q1 2026 at Perspective Therapeutics, up from $2.3 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $2.6 million in Q1 2026 to a low of $154000.0 in Q2 2022.
- A 5-year average of $1.3 million and a median of $1.0 million in 2023 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation surged 771.34% in 2023 and plunged 54.53% in 2024, its largest moves.
- Perspective Therapeutics' Share-based Compensation stood at $496000.0 in 2022, then surged by 39.72% to $693000.0 in 2023, then jumped by 197.26% to $2.1 million in 2024, then grew by 12.09% to $2.3 million in 2025, then advanced by 10.57% to $2.6 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $2.6 million, $2.3 million, and $2.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | 2.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.55 Mn |
| Mar 31, 2026 | 2.55 Mn |
| Dec 31, 2025 | 2.31 Mn |
| Dec 31, 2025 | 2.31 Mn |
| Sep 30, 2025 | 2.16 Mn |
| Sep 30, 2025 | 2.16 Mn |
| Jun 30, 2025 | 2.40 Mn |
| Jun 30, 2025 | 2.40 Mn |
| Mar 31, 2025 | 2.10 Mn |
| Mar 31, 2025 | 2.10 Mn |
| Dec 31, 2024 | 2.06 Mn |
| Dec 31, 2024 | 2.06 Mn |
| Sep 30, 2024 | 1.95 Mn |
| Sep 30, 2024 | 1.95 Mn |
| Jun 30, 2024 | 587,000.00 |
| Jun 30, 2024 | 587,000.00 |
| Mar 31, 2024 | 622,000.00 |
| Mar 31, 2024 | 622,000.00 |
| Dec 31, 2023 | 693,000.00 |
| Dec 31, 2023 | 693,000.00 |
| Sep 30, 2023 | 418,000.00 |
| Sep 30, 2023 | 418,000.00 |
| Jun 30, 2023 | 1.05 Mn |
| Jun 30, 2023 | 1.05 Mn |
| Mar 31, 2023 | 1.37 Mn |
| Mar 31, 2023 | 1.37 Mn |
| Dec 31, 2022 | 496,000.00 |
| Dec 31, 2022 | 496,000.00 |
| Sep 30, 2022 | 465,000.00 |
| Sep 30, 2022 | 465,000.00 |
| Jun 30, 2022 | 154,000.00 |
| Jun 30, 2022 | 154,000.00 |
| Mar 31, 2022 | 157,000.00 |
| Mar 31, 2022 | 157,000.00 |
| Dec 31, 2021 | 180,000.00 |
| Dec 31, 2021 | 180,000.00 |
| Sep 30, 2021 | 596,000.00 |
| Sep 30, 2021 | 596,000.00 |
| Mar 31, 2021 | 94,000.00 |
| Mar 31, 2021 | 94,000.00 |
| Dec 31, 2020 | 81,000.00 |
| Dec 31, 2020 | 81,000.00 |
| Sep 30, 2020 | 85,000.00 |
| Sep 30, 2020 | 85,000.00 |
| Jun 30, 2020 | 219,000.00 |
| Jun 30, 2020 | 219,000.00 |
| Mar 31, 2020 | 91,000.00 |
| Mar 31, 2020 | 91,000.00 |
| Dec 31, 2019 | 94,000.00 |
| Dec 31, 2019 | 94,000.00 |
| Sep 30, 2019 | 91,000.00 |
| Sep 30, 2019 | 91,000.00 |
| Jun 30, 2019 | 151,000.00 |
| Jun 30, 2019 | 151,000.00 |
| Mar 31, 2019 | 79,000.00 |
| Mar 31, 2019 | 79,000.00 |
| Dec 31, 2018 | 97,000.00 |
| Dec 31, 2018 | 97,000.00 |
| Sep 30, 2018 | 93,000.00 |
| Sep 30, 2018 | 93,000.00 |
| Jun 30, 2018 | 87,000.00 |
| Jun 30, 2018 | 87,000.00 |
| Mar 31, 2018 | 77,000.00 |
| Mar 31, 2018 | 77,000.00 |
| Dec 31, 2017 | 78,000.00 |
| Dec 31, 2017 | 78,000.00 |
| Sep 30, 2017 | 90,000.00 |
| Sep 30, 2017 | 90,000.00 |
| Jun 30, 2017 | 210,000.00 |
| Jun 30, 2017 | 210,000.00 |
| Mar 31, 2017 | 40,000.00 |
| Mar 31, 2017 | 40,000.00 |
| Dec 31, 2016 | 52,000.00 |
| Dec 31, 2016 | 52,000.00 |
| Sep 30, 2016 | 70,000.00 |
| Sep 30, 2016 | 70,000.00 |
| Jun 30, 2016 | 61,000.00 |
| Jun 30, 2016 | 61,000.00 |
| Mar 31, 2016 | 166,000.00 |
| Mar 31, 2016 | 166,000.00 |
| Dec 31, 2015 | 31,000.00 |
| Dec 31, 2015 | 31,000.00 |
| Sep 30, 2015 | 32,000.00 |
| Sep 30, 2015 | 32,000.00 |
| Jun 30, 2015 | 140,640.00 |
| Jun 30, 2015 | 140,640.00 |
| Mar 31, 2015 | 21,453.00 |
| Mar 31, 2015 | 21,453.00 |
| Jun 30, 2014 | 120,770.00 |
| Jun 30, 2014 | 120,770.00 |
| Mar 31, 2014 | 13,431.00 |
| Mar 31, 2014 | 13,431.00 |
| Dec 31, 2013 | 13,433.00 |
| Dec 31, 2013 | 13,433.00 |
| Sep 30, 2013 | 38,353.00 |
| Sep 30, 2013 | 38,353.00 |
| Jun 30, 2013 | 22,982.00 |
| Jun 30, 2013 | 22,982.00 |
| Mar 31, 2013 | 27,580.00 |
| Mar 31, 2013 | 27,580.00 |
| Dec 31, 2012 | 28,826.00 |
| Dec 31, 2012 | 28,826.00 |
| Sep 30, 2012 | 28,963.00 |
| Sep 30, 2012 | 28,963.00 |
| Jun 30, 2012 | 73,755.00 |
| Jun 30, 2012 | 73,755.00 |
| Mar 31, 2012 | 33,189.00 |
| Mar 31, 2012 | 33,189.00 |
| Dec 31, 2011 | 33,190.00 |
| Dec 31, 2011 | 33,190.00 |
| Sep 30, 2011 | 33,189.00 |
| Sep 30, 2011 | 33,189.00 |
| Jun 30, 2011 | 174,067.00 |
| Jun 30, 2011 | 174,067.00 |
| Mar 31, 2011 | 20,372.00 |
| Mar 31, 2011 | 20,372.00 |
| Dec 31, 2010 | 23,658.00 |
| Dec 31, 2010 | 23,658.00 |
| Sep 30, 2010 | 24,592.00 |
| Sep 30, 2010 | 24,592.00 |